BioEngage Symposium
Imaging Tools Delivering on the Promise of Precision Cancer Treatment
Schedule
(subject to change)
8:15 - 8:30 Registration
8:30 - 9:00 Networking breakfast
9:00 - 9:15 Welcome and about BioEngage
Presenter: Mike Averkiou
9:15 - 10:30 Session 1: Molecular/targeted contrast agents
Chair: Matt O'Donnell
9:15 - 9:30 Junwei Li, Soon Joon Yoon UW uWAMIT
MNP-bPANI system and molecular imaging
9:30 - 9:45 Rodney Ho Nova TheraNostics & UW
High-resolution MRI and IR diagnostic imaging enabled by a novel biocompatible & biodegradable nano-platform
9:45 - 10:00 Jonathan Liu UW Molecular Biophotonics Lab
Molecular biophotonics for cancer detection and surgical guidance
10:00 - 10:15 Suzie Pun and Kevin Tan UW Pun Lab
Microbubbles and targeted contrast agents
10:15 - 10:30 Eric Seibel UW Human Photonics Lab
Multicolor molecular imaging in the human for GI cancer surveillance
10:30 - 10:45 Introductions
Presenter: Matt O'Donnell
10:45 - 11:15 Break and Posters
See morning poster title and abstracts.
11:15 - 11:45 Panel: Maximizing industry-academic partnerships
Moderator: Matt O'Donnell
Erwin Berthier VP of RND, Tasso Inc
Matt Everett Chief Scientist, Carl Zeiss Meditec Inc
Perry Frederick Research Manager - Western US, GE
Rodney Ho Chair of Scientific Advisory Board, Nova TheraNostics and Professor, UW
Tom Matula Director, UW CIMU
Onno Wink Clinical Scientist, Philips Healthcare
​
11:45 - 12:30 Lunch
12:30 - 1:45 Session 2: Integrated imaging/therapy
Chair: Mike Averkiou
12:30 - 12:45 Matt Everett Carl Zeiss Meditec, Inc.
Technology commercialization - OCT from research concept to mainstream product
12:45 - 1:00 Onno Wink Philips
Challenges with X-ray guided multi-needle tumor ablation
1:00 - 1:15 Matt Nyflot UW Radiation Oncology
Challenges and opportunities for imaging in radiation therapy
1:15 - 1:30 Ine De Cock UW Averkiou Lab/UW uWAMIT
Ultrasound mediated drug delivery
1:30 - 1:45 Jeff Powers Philips
Opening the blood brain barrier to deliver chemotherapy drugs to brain cancer
1:45 - 2:15 Break and Posters
See afternoon poster title and abstracts.
2:15 - 3:30 Session 3: Therapy response assessment
Chair: Jeff Powers
2:15 - 2:30 Savannah Partridge SCCA & UW
Advanced MRI to evaluate response to breast cancer therapy
2:30 - 2:45 Utkarsh Sharma Optovue
OCT angiography: A journey from idea to commercialization
2:45 - 3:00 Andy Milkowski Siemens R&D
Ultrasound fusion as the opportunity to deliver precision cancer treatment
3:00 - 3:15 William Hunter PET/X & UW IRL
Quantitative dual-mode scanner for breast cancer therapy assessment
3:15 - 3:30 Perry Frederick & Siavash Yazdanfar GE
Molecular contrast agents
3:30 - 4:00 Panel: Barriers to clinical acceptance
Moderator: Ray Yueng
Adam Alessio Research Associate Professor, UW Radiology, Imaging Research Lab
Sara St. James Assistant Professor, UW Radiation Oncology
Jonathan Liu Assistant Professor, Molecular Biophotonics Lab
Jessi Parsons Clinical Science Manager, Mirabilis Medical, Inc.
Matt Rielly Clinical Research Board Regional Manager, Philips
Utkarsh Sharma Director, Advanced Development, Optovue
​
4:00 - 5:00 Networking reception